A Multicenter Study Comparing Mirena and Systemic Progestin for Endometrial Hyperplasia.

Trial Profile

A Multicenter Study Comparing Mirena and Systemic Progestin for Endometrial Hyperplasia.

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 11 Aug 2015

At a glance

  • Drugs Levonorgestrel (Primary) ; Medroxyprogesterone (Primary)
  • Indications Endometrial hyperplasia
  • Focus Therapeutic Use
  • Most Recent Events

    • 11 May 2012 Actual patient number is 170 according to ClinicalTrials.gov.
    • 11 May 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
    • 03 Mar 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top